Profitelligence Profitelligence · Filing Ledger Open TMO research →

Form 8-K · Current Report · Filed 2024-07-10

Thermo Fisher Completes Tender Offer for Olink Holding AB

On July 10, 2024, Thermo Fisher Scientific Inc.

Filer
Thermo Fisher Scientific Inc. TMO · NYSE
Filed
Accession
0000950157-24-000978
CIK
0000097745
Signal
Low impactHealthcare

Details

announced the completion of its tender offer by its subsidiary Orion Acquisition AB to purchase all outstanding shares of Olink Holding AB. The results of the tender offer were also announced, marking the end of a significant acquisition activity.

Items reported

Item 8.01

Other Events

Corporate Update
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$531.86

Next session

+2.0%

Since filing

+8.0%

Latest close

$574.30

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from TMO reporting the same item, with the next session's move:

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a world-leading biotechnology company that provides essential tools and services for life sciences, biotechnology, pharmaceutical, and healthcare industries. Renowned for its extensive portfolio, the company specializes in offering innovative laboratory products, analytical instruments, and software solutions critical for research, diagnostics, and clinical applications. Thermo Fisher enables scientists to perform complex experiments with cutting-edge technology, from DNA sequencing and cell analysis to clinical diagnostics and specialty chemicals. Serving a vast array of sectors, the company impacts fields such as diagnostics, genetic engineering, and environmental monitoring. Its strategic acquisitions and collaborations strengthen its market presence, making it a go-to partner for scientific advancements and innovation. With operations spanning over 50 countries, Thermo Fisher plays a pivotal role in driving scientific discovery and improving health outcomes globally.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another TMO filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts